Fenglan Zhang

机构：Qingdao University, Affiliated Hospital of Qingdao University, Qingdao Municipal Hospital · ORCID：0000-0002-7155-0945

发表论文 156 篇 · 总被引 1955 次 · h-index 25

代表论文

• Zn/Cu Bi‐Single‐Atom Nanoplatform: Hexagonal Anti‐Tumor Warrior by ROS Amplification for DOX Resistance Reversal and Immune Activation (2024 · Advanced Functional Materials · 被引 32)
• Temperature-dependent jumonji demethylase modulates flowering time by targeting H3K36me2/3 in Brassica rapa (2024 · Nature Communications · 被引 31)
• Fosfenopril Attenuates Inflammatory Response in Diabetic Dry Eye Models by Inhibiting the TLR4/NF-κB/NLRP3 Signaling Pathway (2024 · Investigative Ophthalmology & Visual Science · 被引 22)
• Cu + /Ca 2+ Dual‐Overload Strategy Assisted by Metabolic‐Symbiotic‐Destruction for Tumor Apoptosis and Tumor Immune Activation (2024 · Advanced Functional Materials · 被引 22)
• Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days (2024 · Digestive Diseases and Sciences · 被引 22)
• “Triple-Hop” nano-bomb combining CDT, PDT and immunetherapy for NIR-triggered cancer therapy (2023 · Chemical Engineering Journal · 被引 17)